Accelerating Alzheimer’s Disease research with Fortrea
Discover Fortrea’s experience and capabilities in Alzheimer’s Disease clinical trials, through exploring our unique patient and caregiver perspectives, site partnerships, and scientific experience.
Behind every Alzheimer’s Disease trial is a story
Hear Carole Stark, who took part in a Fortrea-led study, alongside her husband and caregiver Hank, talk about their clinical trial journey. Discover perspectives from our partner sites and Fortrea leaders driving progress in Alzheimer’s Disease research through our short video series.
Our dedication to Alzheimer’s Disease
A unified, experienced neuroscience team with over 30 years of therapeutic leadership, led by Dr. Leone Atkinson, MD, PhD. Combining depth of academic excellence with an agile approach to real-world drug development experience.
Patient centricity
Patient centricity is core to our methodology. We engage and collaborate with patients and advocacy groups to drive optimally designed protocols and design patient materials to support recruitment.
Digital Health Innovations (DHI)
We integrate approaches that minimize the impact of trial participation on Alzheimer’s Disease patients’ lives - removing barriers to participation and increasing trial access, patient recruitment, engagement and retention.
Cell and Gene therapy opportunities in Alzheimer’s Disease
Delivering complex cell and gene therapy trials for Alzheimer’s Disease requires deep experience and specialized capabilities, from the right site selection to advanced procedural training and patient and family support.
Framed by Carole Stark’s personal story and hope for future generations, the video highlights how innovative neuroscience research is helping shape a future where Alzheimer’s may no longer be a one‑way journey.
The Stark’s story
Carole and Hank Stark share their emotional journey through Alzheimer’s Disease, from the fear and isolation of early symptoms to the hope they found through joining a clinical trial. Their story highlights how research offered not only support for Carole, but renewed optimism for their children and future generations.
Site-CRO relationships
Fortrea’s strong, collaborative site relationships are at the heart of helping to support successful Alzheimer Disease clinical trials. By working closely with investigators, incorporating real‑world insights into protocol design, and maintaining consistent communication, Fortrea aims to provide high‑quality delivery while supporting patients through long, demanding studies.
Want to explore how we can shape your Alzheimer’s Disease research by focusing on real individuals, innovation, scientific experience, and outstanding execution?
At Fortrea, we listen first to the voices of patients, families, and caregivers navigating the realities of Alzheimer’s Disease. Their stories drive our mission and shape every trial we support our clients to design. With over 30 years of hands-on experience in complex Alzheimer’s Disease studies, our neuroscience team brings proven best practices and a relentless commitment to patient centricity. We recognize the unique challenges—cultural attitudes, study burdens, and the need for clear, compassionate education.
That’s why we champion innovative outreach, tailored support, and flexible trial solutions that ease the journey for both patients and their loved ones. In the past five years alone, we’ve delivered over 470 neuroscience trials, including 24 in Alzheimer’s disease, across 60+ countries, collaborating with over 6,500 sites and supporting more than 28,000 patients. Our experience spans the latest advances in precision medicine, biomarker strategies, and decentralized trials, all focused on accelerating breakthroughs that matter. If you’re seeking a CRO which combines scientific rigor with genuine empathy—and who will rally behind your goals at every step—choose Fortrea. Let’s make a difference, together.
Fortrea’s Alzheimer’s Disease insights and experience
Applying a patient- and site-centric approach in an early Phase 1 Alzheimer's Disease study
Sharing our best patient-centric practices from extensive experience in Alzheimer’s Disease
Accelerating clinical research through an integrated team...
“In our neuroscience team, we’re all driven by the same simple truth: Alzheimer’s disease affects not only the people living with it, but also the caregivers and families who support them every single day. Our work brings together science, experience, and compassion, because we understand how deeply this illness impacts everyone involved. And every day, we stay focused on one clear goal: to make a real difference for patients, their caregivers, and their families.”
Discover more about how Fortrea’s accelerating Alzheimer’s Disease research